DEPARTMENT OF LABORATORY MEDICINE

Patient Name : Mrs SAVITRI . Age/Gender : 52 Years/Female

Receiving Date : 30/05/2024 8:06PM UHID : 120720787
Report Date : 31/05/2024 11:05AM Sample Date : 30/05/2024 07:49PM
Prescribed By : Dr PRAWASH KUMAR CHOWDHARY Report Status : Final
Referred By : Specimens : Serum
Ward / Bed No : OPD Lab No : 125803501
INFECTIOUS DISEASE SEROLOGY

Investigation Result Unit Biological Ref. Interval Method

ANTI HCV 0.61 Non-reactive:0.00 to 0.89 Enhanced

Borderline:0.90 to 0.99 Chemiluminescence
Reactive: >= 1.00
ANTI HCV NEGATIVE Non reactive: < 1.0 ELFA
Reactive: >= 1.0
Non-reactive :- This is a screening test for diagnosis of Hepatitis C virus infection. HCV antibody non-reactive indicates no HCV antibody
detected. A non-reactive or negative antibody test means that you are not currently infected with the hepatitis C virus, however does not
exclude early, acute hepatitis C. A negative result may occur if the quantity of the analyte of interest present in the specimen is below
detection limits of the analyte of interest or the analyte of interest that are detected are not present during the stage of the disease in which
the sample is collected. If there is possible exposure to hepatitis C in the last 6 months, a follow up test is indicated after some time or
confirmation by testing for HCV RNA by NAAT may be considered.

Reactive : - A reactive or positive HCV antibody test means the person have been infected with the hepatitis C virus at some point in time
but not necessarily mean that it is a current infection with hepatitis C virus. This marker appears several weeks after exposure and persists
for life. Please send another sample for confirmation of initial reactivity of Anti-HCV status. All hepatitis C antibody positive patients are
potentially infectious and requires further evaluation. An EDTA sample for Hepatitis C virus RNA PCR quantitative to differentiate active
infection from past exposure is recommended. Please consider testing for Liver Function Test.

Do consider proper counseling for appropriate infection control practices. You may please refer the patient to Gastroenterology specialist
(digestive diseases) for further HCV management.

***End Of Report***

SURAJ KUMAR CHOUDHURY PRAKASH CHOUHAN

MD(PHYSICIAN), MD (PATHOLOGY) MBBS,DCP(PATHOLOGY)
CONSULTANT PATHOLOGIST Printed By:
Verified By: 30652
Note: Printed at 31/05/2024 12:42 Page: 1 Of 1
* Clinically Correlate, Kindly discuss if necessary.
* This report relates only to the item received.
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : Mrs SAVITRI . Age/Gender : 52 Years/Female

Receiving Date : 30/05/2024 8:06PM UHID : 120720787
Report Date : 31/05/2024 11:05PM Sample Date : 30/05/2024 07:49PM
Prescribed By : Dr PRAWASH KUMAR CHOWDHARY Report Status : Final
Referred By : Specimens : Serum
Ward / Bed No : OPD Lab No : 125803501
INFECTIOUS DISEASE SEROLOGY

Investigation Result Unit Biological Ref. Interval Method

HBSAG 0.20 S/CO < 1.0 Negative CLIA

0.90 - < 1.0 Gray zone
> 1.0 Positive
HBSAG NEGATIVE

Non-reactive :- This is a screening test for diagnosis of Hepatitis B virus infection. A non-reactive Hepatitis B surface antigen (HBsAg) may
indicate one of the following possibilities, 1. the person is probably not infected , or 2. the quantity of the analyte of interest present in the
specimen is below detection limits of the analyte of interest ,or 3. the analyte of interest that are detected are not present during the stage of
the disease in which the sample is collected. The person may be susceptible to hepatitis B infection or immune to hepatitis B infection due to
natural infection/ vaccination. Consider anti-HBs antibody titres to check immune status and vaccination as applicable.

HBsAg Reactive/ Positive: - Hepatitis B surface antigen (HBsAg) is reactive . HBsAg is a protein on the surface of hepatitis B virus; it can
be detected in high levels in serum during acute or chronic hepatitis B virus infection. The presence of HBsAg indicates that the person is
infectious. Please send another sample for confirmation of initial reactivity of HBsAg. Presence of heterophile antibodies in patient’s
sample with Rheumatic disease and autoimmune disorder may lead to false results.

Please consider testing for Liver function test (LFT), Complete Hepatitis B serology markers including Hepatitis B core total (anti-HBc
total)/ Hepatitis B core Total and IgM (IgM anti-HBc), Hepatitis B e antigen and Hepatitis B e antibodies for clarification of serological
status. Also consider sample for Hepatitis B viral load (HBV DNA). Consider Gastroenterology (digestive diseases) consultation for further
HBV management. Patient needs to be counseled for infection control practices, as well as testing & vaccination for susceptible contacts.

***End Of Report***

SURAJ KUMAR CHOUDHURY PRAKASH CHOUHAN

MD(PHYSICIAN), MD (PATHOLOGY) MBBS,DCP(PATHOLOGY)
CONSULTANT PATHOLOGIST Printed By:
Verified By: 30652
Note: Printed at 31/05/2024 12:43 Page: 1 Of 1
* Clinically Correlate, Kindly discuss if necessary.
* This report relates only to the item received.